- Home
- CRVO vs MKTW Comparison
CRVO vs MKTW Comparison
Compare CRVO & MKTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRVO | MKTW |
|---|---|---|
| Founded | 2001 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.9M | 39.7M |
| IPO Year | 2011 | 2020 |
Fundamental Metrics
Financial Performance| Metric | CRVO | MKTW |
|---|---|---|
| Price | $3.75 | $17.27 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 1 |
| Target Price | ★ $23.00 | $20.00 |
| AVG Volume (30 Days) | ★ 32.3K | 24.0K |
| Earning Date | 05-12-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 10.20% |
| EPS Growth | N/A | ★ 1183.33 |
| EPS | N/A | ★ 2.31 |
| Revenue | $4,006,510.00 | ★ $512,403,000.00 |
| Revenue This Year | N/A | $1.52 |
| Revenue Next Year | N/A | $4.55 |
| P/E Ratio | ★ N/A | $7.26 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.51 | $13.37 |
| 52 Week High | $13.13 | $21.74 |
Technical Indicators
Market Signals| Indicator | CRVO | MKTW |
|---|---|---|
| Relative Strength Index (RSI) | 42.16 | 52.28 |
| Support Level | $3.55 | $16.11 |
| Resistance Level | $4.33 | $17.83 |
| Average True Range (ATR) | 0.24 | 0.79 |
| MACD | 0.00 | -0.06 |
| Stochastic Oscillator | 21.88 | 61.14 |
Price Performance
Historical ComparisonAbout CRVO CervoMed Inc.
CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod, has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
About MKTW MarketWise Inc.
Marketwise Inc is a multi-brand subscription services platform providing premium financial research, software, education, and tools for investors. Its products are built for high-value financial research, education, actionable investment ideas, and investment software. It is a digital, direct-to-consumer company offering its research across a variety of platforms, including mobile, desktop, and tablets.